Biostats Flashcards

1
Q

Cross-Sectional Study

A

Frequency of disease and frequency of risk-related factors are assessed in the present.

Measures DISEASE PREVALENCE.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Case-Control Study

A

Compares a group of people with disease to a group without disease.

Measures ODDS RATIO

*Controls and cases are selected based on DISEASE STATUS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cohort Study

A

Compares a group with a given EXPOSURE or RISK FACTOR to a group without such exposure.

Measures RELATIVE RISK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Crossover Study

A

Compares the effect of a serioes of 2 or more treatments on a participant. Washout period occurs between each treatment.

Allows participants to serve as their own controls.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Twin Concordance Study

A

Compares the frequency with which both monozygotic twins vs. both dizygotic twins develop the same disease.

Measures HERITABILITY and INFLUENCE OF ENVIRONMENTAL FACTORS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adoption Study

A

Compares siblings raised by biological vs. adoptive parents.

Measures HERITABILITY and INFLUENCE OF ENVIRONMENTAL FACTORS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clinical Trial - Phase 1

A

Assesses safety, toxicity, pharmacokinetics, and pharmacodynamics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical Trial - Phase 2

A

Assesses treatment efficacy, optimal dosing and adverse effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clinical Trial - Phase 3

A

Compares the new treatment to the current standard of care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical Trial - Phase 4

A

Detects rare or long-term adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Sensitivity

A

TRUE POSITIVE RATE - portion of all peope with the disease who test positive, or the probability that when the disease is present, the test is positive.

SN-N-OUT: highly sensitive test, when negative, rules OUT disease.

TP/ (TP + FN)

Good for screening tests!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Specificity

A

TRUE NEGATIVE RATE- Proportion of all people without disease who test negative, or the probability that when the disease is absent, the test is negative

SP-P-IN: high specific test, when positive, rules IN disease.

TN/ (TN + FP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Positive Predictive Value

A

Probability that a person who has a positive test result actually has the disease.

PPV= TP / (TP+FP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Negative Predictive Value

A

Probability that a person with a negative test result actually does not have the disease.

NPV= TN/(TN+FN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lowering Cutoff Value

A

Increases FP, Decreases FN

Increases sensitivity and NPV

Decreases specificity and PPV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Raising Cutoff Value

A

Increasing FN, Decreasing FP

Increases specificity and PPV

Decreases sensitivity and NPV

17
Q

Likelihood Ratios

A

Likelihood that a given test result would be expected in a patient with the target disorder compared to the liklihood that the same result would be expected in a patient without the target disorder.

LR+= sensitivity/ (1-specificity)= TP rate/FP rate

LR-= (1-sensitivity) / specificity = FN rate/ TN rate

If LR+ >10 and/or LR- <0.1 indicate a very useful diagnostic test

18
Q

Odds Ratio

A

Depicts odds of certain outcome given an exposure vs the odds of the outcome in the absence of that exposure

Associate with CASE-CONTROL STUDIES

OR= (a/c)/(b/d) = ad/bc

19
Q

Relative Risk

A

Risk of developing disease in the exposed group divided by the risk in the unexposed group.

Associate with COHORT STUDIES (follows people over time)

RR= (a/(a+b))/ (c/(c+d))

RR= 1 : no association b/w exposure and disease

RR>1 : exposure associated with increased disease occurrence

RR<1 : exposure associated with decreased disease occurrence

20
Q

Relative Risk Reduction

A

The proportion of risk reduction attributable to the intervention as compared to a control

RRR= 1- RR

21
Q

Attributable Risk

A

The difference between exposed and unexposed groups

AR = (a/a+b) - (c/c+d)

AR%

22
Q

Absolute Risk Reduction

A

The difference in risk attributable to the intervention as compared to a control

ARR= (c/(c+d)) - (a/(a+b))

23
Q

Number Needed to Treat

A

Number of patients who need to be treated for 1 patient to benefit

NNT= 1/ARR

24
Q

Number Needed to Harm

A

Numer of patients who need to be exposed to a risk factor for 1 patient to be harmed

NNH= 1/AR

25
Q

Case Fatality Rate

A

Percentage of deaths that occur over the disease course

CFR% = deaths/cases x100

26
Q

Incidence

A

Looks at NEW CASES

Incidence= (#new cases) / (# of people at risk)

27
Q

Prevalence

A

Looks at ALL CURRENT CASES in a given population

Prevalence= (# existing cases) / (Total # people in population)

28
Q

Maternal Mortality Rate

A

MMR= (# maternal deaths) / (# live births)